Dermatology NewsGenital psoriasis is the worst: Patients sound offOctober 12, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsIxekizumab has profound impact on genital psoriasisOctober 12, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsTNF inhibitors associated with fewer side effects than methotrexate in children with psoriasisSeptember 30, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsLaunch of adalimumab biosimilar Amjevita postponedSeptember 29, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsSwedish study finds low risk of developing psoriasis in bariatric surgery patientsSeptember 29, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsSmoking linked to increased psoriasis riskSeptember 21, 2017PsoriasisPractice ManagementPsoriatic ArthritisBusiness of Medicine
Dermatology NewsAdjuvant-boosted shingles vaccine earns FDA panel’s unanimous nodSeptember 13, 2017Infectious DiseasesPsoriatic Arthritis
Dermatology NewsFDA approves second adalimumab biosimilar for multiple conditionsAugust 28, 2017PediatricsPsoriatic ArthritisPsoriasis
Dermatology NewsNoninvasive NASH test could help monitor hepatotoxicity in patients on methotrexateAugust 24, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsStudy shows more changes, less stopping of PsA systemic drugsAugust 17, 2017Psoriatic Arthritis
Dermatology NewsPsoriasis, psoriatic arthritis research makes headway at GRAPPA meetingAugust 10, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsStudy finds secukinumab effective for moderate to severe scalp psoriasisAugust 9, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsFDA committee recommends approval of tofacitinib for PsAAugust 3, 2017Psoriatic Arthritis
Dermatology NewsFirst interchangeability study for an adalimumab biosimilar has begunJuly 31, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsUnresolved fatigue lingers for most PsA patientsJuly 17, 2017Psoriatic ArthritisPsoriasis
